======= IER3IP1 ======= == Gene Information == * **Official Symbol**: IER3IP1 * **Official Name**: immediate early response 3 interacting protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51124|51124]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y5U9|Q9Y5U9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IER3IP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IER3IP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609382|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a small protein that is localized to the endoplasmic reticulum (ER) and may play a role in the ER stress response by mediating cell differentiation and apoptosis. Transcription of this gene is regulated by tumor necrosis factor alpha and specificity protein 1 (Sp1). Mutations in this gene may play a role in microcephaly, epilepsy, and diabetes syndrome (MEDS), and a pseudogene of this gene is located on the long arm of chromosome 12. [provided by RefSeq, Dec 2011]. * **UniProt Summary**: May be implicated in the regulation of apoptosis. May be involved in protein transport between endoplasmic reticulum and Golgi apparatus (By similarity). {ECO:0000250}. |Yos1| |regulation of fibroblast apoptotic process| |COPII-coated ER to Golgi transport vesicle| |integral component of Golgi membrane| |endoplasmic reticulum to Golgi vesicle-mediated transport| |Golgi vesicle transport| |endoplasmic reticulum membrane| |Golgi apparatus| |endoplasmic reticulum| |intracellular transport| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of cell death| |establishment of localization in cell| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-3.16| |[[:results:exp469|CFI-400945 25μM R08 exp469]]|-2.3| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-2.27| |[[:results:exp169|BH1 1μM R04 exp169]]|-2.06| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|-1.91| |[[:results:exp247|UM0130462 0.025 to 0.035μM day4 R05 exp247]]|-1.83| |[[:results:exp123|GSK-LSD1 10μM R03 exp123]]|1.74| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.74| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.76| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|1.9| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|2.04| |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|2.05| |[[:results:exp300|VE-822 0.04μM R06 exp300]]|2.07| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|2.1| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|2.16| |[[:results:exp49|NFN1 0.1μM R01 exp49]]|2.36| |[[:results:exp59|UMK57 1μM R01 exp59]]|2.72| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|2.78| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|2.82| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|2.89| ^Gene^Correlation^ |[[:human genes:y:yipf5|YIPF5]]|0.43| Global Fraction of Cell Lines Where Essential: 14/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|1/17| |esophagus|1/13| |fibroblast|0/1| |gastric|0/16| |kidney|1/21| |liver|1/20| |lung|2/75| |lymphocyte|2/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13885 * **Expression level (log2 read counts)**: 5.17 {{:chemogenomics:nalm6 dist.png?nolink |}}